Ghent University Academic Bibliography

Mark

Angiopoietin-2 promotes pathological angiogenesis and is a novel therapeutic target in murine non-alcoholic fatty liver disease

Sander Lefere (UGent) , Frederique Van de Velde (UGent) , Anne Hoorens (UGent) , Sarah Raevens (UGent) , Sanne Van Campenhout (UGent) , Astrid Vandierendonck (UGent) , Sara Neyt (UGent) , Bert Vandeghinste (UGent) , Christian Vanhove (UGent) , Charlotte Debbaut (UGent) , et al.

(2019) HEPATOLOGY.

Mark

journalArticle

Why Pulse Oximetry Is Inaccurate in Liver Cirrhosis: Ancient Knowledge

Sarah Raevens, Isabelle Colle, Anja Geerts and Hans Van Vlierberghe

(2019) Hepatology. 69(1). p.462-463

Mark

conference

Alkaline Phosphatase Normalization Is Associated with a Decreased Risk for Liver Transplantation and Death in Patients with Primary Biliary Cholangitis

Carla Fiorella Murillo Perez, Aliya Gulamhusein, Christophe Corpechot, Adriaan Van der Meer, Henk R. Van Buuren, Pietro Invernizzi, Palak Trivedi, Frederik Nevens, Marlyn J. Mayo, Pier Maria Battezzati, et al.

(2018) HEPATOLOGY. 68. p.1085A-1086A

Mark

journalArticle

Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice

Sarah Raevens, Anja Geerts, Annelies Paridaens, Sander Lefere, Xavier Verhelst (UGent) , Anne Hoorens, Jo Van Dorpe, Tania Maes, Ken R. Bracke, Christophe Casteleyn, et al.

(2018) HEPATOLOGY. 68(2). p.634-651

Mark

Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice

Sarah Raevens (UGent) , Anja Geerts (UGent) , Annelies Paridaens (UGent) , Sander Lefere (UGent) , Xavier Verhelst (UGent) , Anne Hoorens (UGent) , Jo Van Dorpe (UGent) , Tania Maes (UGent) , Ken Bracke (UGent) , Christophe Casteleyn (UGent) , et al.

(2018) HEPATOLOGY. 68(2). p.634-651

Mark

conference

Angiopoietin-2 Promotes Pathological Angiogenesis and Is a Novel Therapeutic Target in Non-Alcoholic Fatty Liver Disease

Sander Lefere, Frederigue Van de Velde, Anne Hoorens, Sarah Raevens, Sanne Van Campenhour, Astrid Vandierendonck, Sara Neyt, Bert Vandeghinste, Christian Vanhove, Charlotte Debbaur, et al.

(2018) HEPATOLOGY. 68. p.753A-753A

Mark

conference

A New "Treatment-Response Score" for AUTO Immune Hepatitis Is Predictive of LONG-TERM Event-Free Survival and Overall Survival. a Multicenter Belgian Cohort Study.

Cedric Simoen, Jeoffrey Schouten, Isabelle Colle, Christophe van Steenkiste, Filip Sermon, Anne Hoorens, Anja Geerts, Hans Van Vlierberghe and Xavier Verhelst (UGent)

(2018) HEPATOLOGY. 68. p.1126A-1126A

Mark

conference

Validation of the Amsterdam-Oxford Survival Prediction Model in Primary Sclerosing Cholangitis in a Tertiary Center Setting

Jorn Goet, Annarosa Floreani, Xavier Verhelst (UGent) , Nora Cazzagon, Lisa Perini, Willem J. Lammers, Adriaan Van Der Meer, Annemarie C. De Vries, Henk R. van Buuren and Bettina E. Hansen

(2018) HEPATOLOGY. 68. p.1076A-1077A

Mark

journalArticle

Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history

Carla F. Murillo Perez, Jorn C. Goet, Willem J. Lammers, Aliya Gulamhusein, Henk R. van Buuren, Cyriel Y. Ponsioen, Marco Carbone, Andrew Mason, Christophe Corpechot, Pietro Invernizzi, et al.

(2018) HEPATOLOGY. 67(5). p.1920-1930

Mark

conference

Angiopoietin‐2 Promotes Pathological Angiogenesis and Is a Novel Therapeutic Target in Non‐Alcoholic Fatty Liver Disease

Sander Lefere (UGent) , Frederique Van de Velde (UGent) , Anne Hoorens (UGent) , Sarah Raevens (UGent) , Sanne Van Campenhout (UGent) , Astrid Vandierendonck (UGent) , Sara Neyt (UGent) , Bert Vandeghinste (UGent) , Christian Vanhove (UGent) , Charlotte Debbaut (UGent) , et al.

(2018) In Hepatology 68(S1). p.753A-753A

Academic Bibliography

Angiopoietin-2 promotes pathological angiogenesis and is a novel therapeutic target in murine non-alcoholic fatty liver disease

Why Pulse Oximetry Is Inaccurate in Liver Cirrhosis: Ancient Knowledge

Alkaline Phosphatase Normalization Is Associated with a Decreased Risk for Liver Transplantation and Death in Patients with Primary Biliary Cholangitis

Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice

Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice

Angiopoietin-2 Promotes Pathological Angiogenesis and Is a Novel Therapeutic Target in Non-Alcoholic Fatty Liver Disease

A New "Treatment-Response Score" for AUTO Immune Hepatitis Is Predictive of LONG-TERM Event-Free Survival and Overall Survival. a Multicenter Belgian Cohort Study.

Validation of the Amsterdam-Oxford Survival Prediction Model in Primary Sclerosing Cholangitis in a Tertiary Center Setting

Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history

Angiopoietin‐2 Promotes Pathological Angiogenesis and Is a Novel Therapeutic Target in Non‐Alcoholic Fatty Liver Disease

Contents

Support

Contact